Some people need GLP-1s
Rekha Kumar, a practicing endocrinologist in New York City, told Flow Space that this can be due to low blood sugar levels, which can be a side effect of taking GLP-1 drugs
Improves kidney function and can reverse anemia
Maintenance Phase 1 NAD+ IV treatment every 46 weeks This phase sustains therapeutic NAD+ concentrations, supports ongoing neural regeneration, preserves cognitive performance, and maintains systemic metabolic efficiency over time
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Accordingly, macrophage depletion via small molecule inhibition of the pro-survival receptor CSF1R is sufficient to reduce OL loss and demyelination in the cuprizone model, and administration of the ligand CSF1 is sufficient to cause demyelination 172